Does cancer risk increase with HbA 1c, independent of diabetes?

British Journal of Cancer

Volumn 110, Issue 9, 2014, Pages 2361-2368

  De Beer, J C ^a   Liebenberg, L ^a,b  

^a NORTH WEST UNIVERSITY   (South Africa)

^b TEMM International (Pty) Ltd   (South Africa)

Author keywords

cancer prevention; cancer risk; diabetes; hyperglycaemia; pre diabetes

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN A1C;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CHRONIC DISEASE; COLORECTAL CANCER; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; GLEASON SCORE; GYNECOLOGIC CANCER; HUMAN; HYPERGLYCEMIA; LEUKEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STOMACH CANCER; UTERUS CANCER;

BIOLOGICAL MARKERS; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; NEOPLASMS; RISK FACTORS; SOUTH AFRICA;

EID: 84899961582     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.150     Document Type: Article

References (55)

1. American Diabetes Association (2013) Standards of medical care in diabetes - 2013. Diabetes Care 36(Suppl 1) S11-S66.
2. Coussens LM, Zitvogel L, Palucka AK (2013) Neutralizing tumor-promoting chronic inflammation: a magic bullet. Science 339(6117): 286-291.
3. Crippa A (2013) Dosresmeta: Performing dose-response meta-analysis, computer software, http://cran.r-project.org/web/packages/dosresmeta/ index.html.
4. Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, Kaaks R, Jonsson H, Stattin P (2009) The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat 113(3): 567-576.
5. Donadon V, Balbi M, Valent F, Avogaro A (2010) Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol 16(24): 3025-3032.
6. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP (2011) Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 29(1): 54-60.
7. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7): 1674-1685.
8. Grote VA, Rohrmann S, Nieters A, Dossus L, Tjønneland A, Halkjær J, Overvad K, Fagherazzi G, Boutron-Ruault MC, Morois S, Teucher B, Becker S, Sluik D, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Vineis P, Panico S, Rodríguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink SM, Beulens JW, Peeters PH, Sund M, Ye W, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen N, Crowe F, Jenab M, Romieu I, Michaud DS, Riboli E, Romaguera D, Bueno-de-Mesquita HB, Kaaks R (2011) Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54(12): 3037-3046.
9. Habib SL, Rojna M (2013) Diabetes and risk of cancer. ISRN Oncol 2013: 583786.
10. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5): 646-674.
11. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC (2006) Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 163(11): 1042-1052.
12. Hong SK, Lee ST, Kim SS, Min KE, Byun SS, Cho SY, Choe G, Lee SE (2009) Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer. Prostate 69(8): 820-826.
13. Hsu YC, Chiu HM, Liou JM, Chang CC, Lin JT, Liu HH, Wu MS (2012) Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia. Cancer Causes Control 23(2): 321-328.
14. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y (2009) Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 136(4): 1234-1241.
15. Johnson JA, Bowker SL (2011) Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54(1): 25-31.
16. Joshu CE, Prizment AE, Dluzniewski PJ, Menke A, Folsom AR, Coresh J, Yeh HC, Brancati FL, Platz EA, Selvin E (2012) Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) study, 1990-2006. Int J Cancer 131(7): 1667-1677.
17. Kaneda K, Uenishi T, Takemura S, ShinkawaH, Urata Y, Sakae M, Yamamoto T, Kubo S (2012) The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 105(6): 606-611.
18. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European Prospective Investigation into Cancer - Norfolk Study. Cancer Epidemiol Biomarkers Prev 13(6): 915-919.
19. Kim HS, Presti Jr JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ (2010a) Glycemic control and prostate cancer progression: results from the SEARCH database. Prostate 70(14): 1540-1546.
20. Kim BJ, Kim YH, Sinn DH, Kang KJ, Kim JY, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC (2010b) Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males. Cancer Causes Control 21(6): 939-944.
21. Krone CA, Ely JTA (2005) Controlling hyperglycemia as an adjunct to cancer therapy. Integr Cancer Ther 4(1): 25-31.
22. Levitan EB, Liu S, Stampfer MJ, Cook NR, Rexrode KM, Ridker PM, Buring JE, Manson JE (2008) HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 51(2): 267-275.
23. Levran D, Modan M, Menczer J, Dulitzy M (1984) Increased rate of glucose intolerance in endometrial cancer - a community-based study. Gynecol Obstet Invest 18(4): 190-193.
24. Lin J, Ridker PM, Pradhan A, Lee IM, Manson JE, Cook NR, Buring JE, Zhang SM (2005) Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14(12): 3010-3012.
25. Lin J, Ridker PM, Rifai N, Lee IM, Manson JE, Buring JE, Zhang SM (2006) A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res 66(5): 2869-2875.
26. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11): 2011-2030.
27. Mathews EH, Liebenberg L (2013) Short-term starvation for cancer control in humans. Exp Gerontol 48(11): 1293.
28. Miao Jonasson J, Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjörnsdottir S (2012) HbA1c and cancer risk in patients with type 2 diabetes-a nationwide population-based prospective cohort study in Sweden. PLoS One 7(6): e38784.
29. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4): 264-269.
30. Montaruli A, Patrini P, Roveda E, Carandente F (2012) Physical activity and breast cancer. Sport Sci Health 8(1): 1-13.
31. Nemesure B, Wu SY, Hambleton IR, Leske MC, Hennis AJ. Barbados National Cancer Study Group (2009) Risk factors for breast cancer in a black population - The Barbados National Cancer Study. Int J Cancer 124(1): 174-179.
32. Onodera Y, Nam JM, Bissell MJ (2014) Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways. J Clin Invest 124(1): 367-384.
33. Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1): 40-57.
34. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1): 66-73.
35. Patterson RE, Rock CL, Kerr J, Natarajan L, Marshall SJ, Pakiz B, Cadmus-Bertram LA (2013) Metabolism and breast cancer risk: frontiers in research and practice. J Acad Nutr Diet 113(2): 288-296.
36. Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114(1): 63-70.
37. Platz EA, Hankinson SE, Rifai N, Colditz GA, Speizer FE, Giovannucci E (1999) Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 10(5): 379-386.
38. Pollak M (2012) The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 12(3): 159-169.
39. R Core Team (2013) R: A language and environment for statistical computing, computer software, http://www.R-project.org/.
40. Rinaldi S, Rohrmann S, Jenab M, Biessy C, Sieri S, Palli D, Tumino R, Mattiello A, Vineis P, Nieters A, Linseisen J, Pischon T, Boeing H, Hallmans G, Palmqvist R, Manjer J, Wirfält E, Crowe FL, Khaw KT, Bingham S, Tjønneland A, Olsen A, Overvad K, Lund E, Skeie G, Clavel-Chapelon F, Boutron-Ruault MC, de Lauzon-Guillain B, Ardanaz E, Jakszyn P, Ramon Quiros J, Chirlaque MD, Sanchez MJ, Dorronsoro M, Trichopoulou A, Lagiou P, Trichopoulos D, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, Slimani N, Ferrari P, Byrnes GB, Riboli E, Kaaks R (2008) Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 17(11): 3108-3115.
41. Robien K, Rock CL, Demark-Wahnefried W (2013) Nutrition and cancers of the breast, endometrium, and ovary. In: Nutrition in the Prevention and Treatment of Disease, Coulston AM, Boushey CJ, Ferruzzi MG (eds) pp 657-672. Elsevier: London.
42. Rusu F, Rusu E, Radulian G, Enache G, Jinga M, Rusu A, Jinga V, Codreanu O, Mischianu D, Cheta D (2011) Screening for prostatic tumors in metabolic syndrome patients in Romania. Acta Endo 7(1): 47-58.
43. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ (2003) Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 12(5): 412-418.
44. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B (2008a) Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci 53(9): 2486-2494.
45. Siddiqui AA, Maddur H, Naik S, Cryer B (2008b) The association of elevated HbA1c on the behavior of adenomatous polyps in patients with type-II diabetes mellitus. Dig Dis Sci 53(4): 1042-1047.
46. Stevens EE, Yu S, Van Sise M, Pradhan TS, Lee V, Pearl ML, Lee YC, Abulafia O (2012) Hemoglobin A1c and the relationship to stage and grade of endometrial cancer. Arch Gynecol Obstet 286(6): 1507-1512.
47. Stocks T, Lukanova A, Johansson M, Rinaldi S, Palmqvist R, Hallmans G, Kaaks R, Stattin P (2008) Components of the metabolic syndrome and colorectal cancer risk: a prospective study. Int J Obes 32(2): 304-314.
48. Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120(12): 2678-2686.
49. Travier N, Jeffreys M, Brewer N, Wright CS, Cunningham CW, Hornell J, Pearce N (2007) Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 18(8): 1414-1419.
50. Wagner KH, Brath H (2012) A global view on the development of non communicable diseases. Prev Med 54(Suppl): S38-S41.
51. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E (2005) A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 14(4): 850-855.
52. Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci E (2006) C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 15(4): 750-755.
53. World Health Organization (2010) Global Status Report on Noncommunicable Diseases 2010.
54. Yadav NK, Poudel B, Thanpari C, Chandra Koner B (2012) Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer. Asian Pac J Cancer Prev 13(7): 3385-3388.
55. Yang YX, Habel LA, Capra AM, Achacoso NS, Quesenberry Jr CP, Ferrara A, Levin TR, Lewis JD (2010) Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev 19(12): 3027-3036.